Urology & Kidney Drugs
Prescription drugs and medicines for conditions and diseases relating to the kidneys and the urinary tract. Studies in these areas include: bladder cancer, impotence, kidney disease, kidney stones, mastectomy, nocturia, renal cell carcinoma, urinary tract infections, and others.
The list of FDA approved drugs for urology and nephrology appears below. Click any link to view the full drug information.
For the treatment of renal cell carcinoma
For the treatment of overactive bladder
For the treatment of renal cell carcinoma
For the treatment of hyperammonemia
Treatment for impotence
Respiratory tract infections
Treatment for cystitis
For the treatment of prostate cancer
Treatment for an overactive bladder
For the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency
Treatment for overactive bladder
Treatment for and Overactive Bladder
For the treatment of intra-abdominal infections and urinary tract infections
For the treatment of symptomatic benign prostatic hyperplasia
Treatment for erectile dysfunction
For the palliative treatment of advanced prostate cancer
Treatment for interstitial cystitis
Treatment for prostate cancer
For the treatment of Fabry disease in adult patients
For the treatment of iron deficiency anemia associated with chronic kidney disease
Treatment for benign prostatic hypertrophy (BPH)
For the treatment of hyperphosphatemia related to kidney dysfunction
For the treatment of overactive bladder
Treatment for pancreatic cancer
To reduce iPTH levels in management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis
For the treatment of advanced renal cell carcinoma
Treatment for incontinence
Once-daily injectable treatment for bacterial infections
For the treatment of benign prostatic hyperplasia
For the treatment of prostate cancer
Treatment for urinary tract infection
Treatment for advanced prostate cancer
Oral tablet to inhibit the hemorrhagic cystitis induced by Ifex (ifosfamide)
For the treatment of anemia associated with chronic renal failure
Treatment for uncomplicated urinary tract infection
Treatment for vitamin B-12 deficiency
For the prevention of organ rejection following kidney transplant
For the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
Oral capsules and gelcaps for the control of hyperphosphatemia in end stage renal failure
Treatment for the prevention of kidney transplant rejection
Treatment for complication relating to benign prostatic hyperplasia (BPH)
For the treatment of hormone refractory prostate cancer
For treatment of kidney rejection
For the control of serum phosphorus in patients with chronic kidney disease on dialysis
For the reduction of serum phosphorus in patients with end-stage renal disease (ESRD)
Treatment for Renal Disease
For the control of serum phosphorus in patients with chronic kidney disease on dialysis
For the treatment of overactive bladder with symptoms of urge urinary incontinence
For the treatment of secondary hyperparathyroidism and hypercalcemia in parathyroid carcinoma patients
Treatment for the reduction of scar tissue as a result of abdominal or pelvic surgery
Treatment for acute organ transplant rejection
For the treatment of atypical hemolytic uremic syndrome
Tequin (Injectable and Tablet)
For the treatment of renal cell carcinoma
For the treatment of overactive bladder
For the palliative treatment of advanced prostate cancer
Intramuscular injection for the treatment of advanced stage prostate cancer
For the treatment of of the signs and symptoms of benign prostatic hyperplasia
For the treatment of euvolemic hyponatremia
For the treatment of iron deficiency anemia in patients undergoing chronic hemodialysis
For the treatment of overactive bladder with symptoms of urge urinary incontinence
For pain relief in men with advanced prostate cancer
Diagnostic contrast agent
For the treatment of toxic plasma methotrexate concentrations in patients with impaired renal function
For the treatment of renal cell carcinoma
For the treatment of hepatic encephalopathy
Treatment of secondary hyperparathyroidism associated with chronic renal failure
Treatment to prevent rejection of kidney transplants
Treatment for advanced prostate cancer
For the prevention of organ rejection following kidney transplant
FDA Approved Urology & Kidney Drugs Listings:
The rules of principle for evaluating MediLexicon's FDA urology & kidney drugs listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.
MediLexicon's FDA Approved Drugs Listings include:
New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.
MediLexicon's FDA Approved Drugs Listings do NOT include:
Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.
The urology & kidney drugs information used in this section is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
